|
PVCT Provectus Biopharmaceuticals Inc 315545 |
| Balance Sheet |
|
Current Assets
|
$1,368,884.00 |
|
Assets
|
$1,473,501.00 |
|
Current Liabilities
|
$7,707,145.00 |
|
Liabilities
|
$7,761,065.00 |
|
Equity
|
$-6,275,171.00 |
|
Shares Out
|
420279879.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-715,814.00 |
| Market Analysis |
Market Cap
|
$21,013,993.95 |
|
Price
|
$0.05 |
|
PB
|
0.13 |
|
PS
|
75.03 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:35 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PVCT documents filed with the SEC.
PVCT Filings
Clear
